Generic dossier
Tofacitinib citrate
11 mg, 22 mg · ER tablet · Immunomodulator
Product data
- Strength
- 11 mg, 22 mg
- Dosage form
- ER tablet
- Dosage-form group
- Oral solid
- Therapeutic area
- Immunomodulator
- Market
- EU/US
- Status
- Dossier ready
- Development status
- Pilot bio with 6-month stability done; ready for tech transfer
- Portfolio
- Generic dossier
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23